Curaleaf's 1-for-3 Reverse Stock Split Paves Way for U.S. Uplisting

Curaleaf Announces Major Share Consolidation Strategy

Curaleaf Holdings, Inc., a prominent player in the international cannabis market, has recently made a significant announcement regarding a 1-for-3 reverse stock split. This decision is a strategic move in anticipation of an uplisting to a major U.S. stock exchange, timed perfectly with potential changes in cannabis legislation.

The reverse stock split, set to take effect on or about June 5, 2026, aims to consolidate shares at a ratio where every three shares will be combined into one. By implementing this approach, Curaleaf’s leadership, guided by its Board of Directors, seeks to enhance the company's equity structure and meet specific share price criteria established by U.S. exchanges, which is critical as the regulatory landscape for cannabis continues to evolve.

In a recent statement, Boris Jordan, Curaleaf's Chairman and CEO, emphasized the company’s commitment to achieving a listing on a U.S. stock exchange. Jordan underscored that the recent rescheduling of medical cannabis at the federal level could provide a gateway for Curaleaf to elevate its listing, making it strategically poised for future growth and investor engagement.

As the number of outstanding subordinate voting shares is poised to decrease from approximately 698 million to about 233 million, the anticipated outcome is an increase in the trading price per share. This will not only meet the requirements set forth by exchanges but also potentially attract institutional investors who seek more stabilized stock metrics.

Moreover, the reverse split is anticipated to expand shareholder participation, improving access to capital, and further legitimizing the cannabis industry in public markets. Curaleaf's robust internal structures, combined with favorable government guidance surrounding the cannabis sector, positions the company to capitalize on forthcoming changes, particularly with regulatory clarity expected soon.

The board's resolution has already received conditional approval from the Ontario Stock Exchange, ensuring that Curaleaf’s shares will continue to trade under the symbol CURA following the consolidation. Shareholders will receive detailed instructions via a Letter of Transmittal on how to exchange their shares, ensuring a smooth transition as the company navigates this pivotal phase.

Furthermore, Curaleaf is committed to keeping shareholders informed throughout this process. They have established a dedicated FAQ page to answer any questions regarding the reverse stock split and its implications for investors.

Curaleaf Holdings stands as a testament to the burgeoning cannabis industry, showcasing a commitment to quality and community-focused cultivation of cannabis products. The company's various brands, such as Select, Grassroots, and Anthem, exemplify its dedication to innovation and customer satisfaction. As it moves towards an uplisting, Curaleaf aims to foster growth that benefits not only shareholders but also the wider community reliant on the positive impacts of cannabis.

In conclusion, Curaleaf's strategic decision to proceed with a reverse stock split signals its readiness to adapt to market conditions and regulatory changes. Stakeholders are encouraged to follow the developments closely, as Curaleaf positions itself for increased visibility and performance in the dynamic landscape of the cannabis industry. As discussions around federal cannabis regulations are expected to ramp up, Curaleaf is primed to swiftly harness emerging opportunities within the sector.

For more detailed inquiries, investors can visit Curaleaf’s investor relations page and stay abreast of ongoing developments that will influence the company’s trajectory during this critical juncture.